Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

AbCellera Biologics Inc. (ABCL) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/25/2023 4 Hansen Carl L. G. (CEO) has filed a Form 4 on AbCellera Biologics Inc.
Txns: Exercised 56,125 options to buy @ $2.7, valued at $151.5k
08/09/2023 4 Hayden Michael R (Director) has filed a Form 4 on AbCellera Biologics Inc.
Txns: Bought 30,000 shares @ $5.9, valued at $177k
05/26/2023 4 Booth Andrew (CFO) has filed a Form 4 on AbCellera Biologics Inc.
Txns: Bought 14,500 shares @ $6.85, valued at $99.3k
05/26/2023 4 Thermopylae Holdings Ltd. (10% Owner) has filed a Form 4 on AbCellera Biologics Inc.
Txns: Bought 153,000 shares @ $6.5211, valued at $997.7k
05/09/2023 4 Lecault Veronique (COO) has filed a Form 4 on AbCellera Biologics Inc.
Txns: Exercised 250,000 options to buy @ $0.19, valued at $47.5k
02/23/2023 4 Hansen Carl L. G. (CEO) has filed a Form 4 on AbCellera Biologics Inc.
Txns: Exercised 56,125 options to buy @ $2.7, valued at $151.5k
12/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/22/2022 4 Thermopylae Holdings Ltd. (10% Owner) has filed a Form 4 on AbCellera Biologics Inc.
Txns: Bought 200,000 shares @ $11.4623, valued at $2.3M
08/22/2022 4 Hansen Carl L. G. (CEO) has filed a Form 4 on AbCellera Biologics Inc.
Txns: Exercised 56,125 options to buy @ $2.7, valued at $151.5k
06/15/2022 4 Thermopylae Holdings Ltd. (10% Owner) has filed a Form 4 on AbCellera Biologics Inc.
Txns: Bought 54,915 shares @ $8.0318, valued at $441.1k
Bought 9,173 shares @ $8.0499, valued at $73.8k
06/08/2022 4 Thermopylae Holdings Ltd. (10% Owner) has filed a Form 4 on AbCellera Biologics Inc.
Txns: Bought 64,545 shares @ $7.4981, valued at $484k
05/19/2022 4 Hansen Carl L. G. (CEO) has filed a Form 4 on AbCellera Biologics Inc.
Txns: Exercised 56,125 options to buy @ $2.7, valued at $151.5k
05/17/2022 4 Lecault Veronique (COO) has filed a Form 4 on AbCellera Biologics Inc.
Txns: Bought 200,000 shares @ $6.3389, valued at $1.3M
05/17/2022 4 Thermopylae Holdings Ltd. (10% Owner) has filed a Form 4 on AbCellera Biologics Inc.
Txns: Bought 300,000 shares @ $7.2551, valued at $2.2M
05/16/2022 4 Thermopylae Holdings Ltd. (10% Owner) has filed a Form 4 on AbCellera Biologics Inc.
Txns: Bought 1,408,468 shares @ $6.4054, valued at $9M
05/16/2022 4 Booth Andrew (CFO) has filed a Form 4 on AbCellera Biologics Inc.
Txns: Bought 85,000 shares @ $5.79, valued at $492.2k
03/04/2022 4 Montalbano John S. (Director) has filed a Form 4 on AbCellera Biologics Inc.
Txns: Bought 10,000 shares @ $8.54, valued at $85.4k
03/03/2022 4 Montalbano John S. (Director) has filed a Form 4 on AbCellera Biologics Inc.
Txns: Bought 20,000 shares @ $9.05, valued at $181k
03/01/2022 4 Lecault Veronique (COO) has filed a Form 4 on AbCellera Biologics Inc.
Txns: Bought 230,789 shares @ $8.66, valued at $2M
02/25/2022 4 Hansen Carl L. G. (CEO) has filed a Form 4 on AbCellera Biologics Inc.
Txns: Exercised 56,125 options to buy @ $2.7, valued at $151.5k
12/10/2021 4 Booth Andrew (CFO) has filed a Form 4 on AbCellera Biologics Inc.
Txns: Exercised 500,000 options to buy @ $0.32, valued at $160k
12/10/2021 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
12/10/2021 4 Montalbano John S. (Director) has filed a Form 4 on AbCellera Biologics Inc.
Txns: Granted 34,282 options to buy @ $17.58, valued at $602.7k
Granted 45,532 options to buy @ $14.55, valued at $662.5k
12/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy